| Authors: |
Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: jhaverik@mskcc.org., Eli LD; Clinical Development, Puma Biotechnology, Los Angeles, USA., Wildiers H; University Hospitals Leuven, Leuven, Belgium., Hurvitz SA; David Geffen School of Medicine, UCLA, Los Angeles, Santa Monica, USA., Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Unni N; UT Southwestern Medical Center, Dallas., Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh., Park H; Washington University School of Medicine, St. Louis., Waisman J; City of Hope Comprehensive Cancer Center, Duarte., Yang ES; University of Alabama at Birmingham, Birmingham, USA., Spanggaard I; Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark., Reid S; Division of Hematology/Oncology (Breast Oncology), The Vanderbilt-Ingram Cancer Center, Nashville., Burkard ME; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison., Vinayak S; Seattle Cancer Care Alliance, Seattle, USA., Prat A; Hospital Clínic de Barcelona, Barcelona, Spain., Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif., Bidard FC; Department of Medical Oncology, UVSQ/Paris-Saclay University, Institut Curie, Saint Cloud, France., Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia., Crown J; St. Vincent's University Hospital, Dublin, Ireland., Bhave M; Department of Hematology/Oncology, Emory University, Winship Cancer Institute, Atlanta., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston., Suga JM; Kaiser Permanente, Department of Medical Oncology, Vallejo, USA., Chia S; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada., Saura C; Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Garcia-Saenz JÁ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid., Gambardella V; Hospital Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia., de Miguel MJ; START Madrid - Hospital Universitario Madrid Sanchinarro, Madrid, Spain., Gal-Yam EN; Institute of Breast Oncology, Sheba Medical Center, Ramat Gan., Rapael A; Sourasky Medical Center, Tel Aviv., Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Tel Aviv University, Tel Aviv, Israel., Ma C; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Hanker AB; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Ye D; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Goldman JW; UCLA Hematology & Oncology, Santa Monica., Bose R; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Peterson L; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis., Bell JSK; Tempus Labs, Chicago, USA., Frazier A; Clinical Development, Puma Biotechnology, Los Angeles, USA., DiPrimeo D; Clinical Development, Puma Biotechnology, Los Angeles, USA., Wong A; Clinical Development, Puma Biotechnology, Los Angeles, USA., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas., Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. |
